BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siddiqui M, Vora A, Ali S, Abramowitz J, Mirfakhraee S. Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia. J Endocr Soc 2021;5:bvaa171. [PMID: 33294765 DOI: 10.1210/jendso/bvaa171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Husni H, Khan SA, Alghaieb B, Abusamaan MS, Donner TW, Hamrahian AH. Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: A case report and review of the literature. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5650] [Reference Citation Analysis]
2 Kurakawa KI, Okada A, Manaka K, Konishi T, Jo T, Ono S, Uda K, Michihata N, Matsui H, Fushimi K, Yamaguchi S, Yamauchi T, Nangaku M, Yasunaga H, Kadowaki T. Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan. J Clin Endocrinol Metab 2021:dgab559. [PMID: 34343300 DOI: 10.1210/clinem/dgab559] [Reference Citation Analysis]
3 Capodanno Y, Altieri B, Elders R, Colao A, Faggiano A, Schrader J. Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies. Transl Oncol 2021;15:101269. [PMID: 34794032 DOI: 10.1016/j.tranon.2021.101269] [Reference Citation Analysis]
4 Oziel-taieb S, Maniry-quellier J, Chanez B, Poizat F, Ewald J, Niccoli P. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature. Front Endocrinol 2022;13:860614. [DOI: 10.3389/fendo.2022.860614] [Reference Citation Analysis]
5 Valea A, Sandru F, Petca A, Dumitrascu MC, Carsote M, Petca RC, Ghemigian A. Aggressive prolactinoma (Review). Exp Ther Med 2022;23:74. [PMID: 34934445 DOI: 10.3892/etm.2021.10997] [Reference Citation Analysis]
6 Chen Q, Wang WJ, Jia YX, Yuan H, Wu PF, Ge WL, Meng LD, Huang XM, Shen P, Yang TY, Miao Y, Zhang JJ, Jiang KR. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell Biosci 2021;11:86. [PMID: 33985581 DOI: 10.1186/s13578-021-00602-8] [Reference Citation Analysis]